Course Overview
Case Studies in Oncologic Emergencies: Tumor Lysis Syndrome in Adults with Leukemia
In collaboration with Oncology Today™, this series also includes a certified CME Webcast and an additional case study.
- Oncologic Emergencies: Nephropathy and Tumor Lysis Syndrome
- Case Studies in Oncologic Emergencies: Tumor Lysis Syndrome and Hemolysis in Acute Lymphoblastic Leukemia
Overview: Tumor lysis syndrome (TLS) is an oncologic emergency characterized by metabolic derangements resulting from tumor breakdown, which leads to a number of clinical manifestations including renal failure, fluid overload, edema, cardiac dysrhythmias, and sudden death. While TLS usually occurs after the initiation of cytotoxic therapy, it may occur spontaneously. Although the tumor-related risk factors known to contribute to TLS are common characteristics of hematological malignancies, TLS has recently been reported in patients with solid tumors and tumor types not typically associated with TLS. This program will focus on the identification and stratification of patients at risk of TLS, as well as the management of TLS once identified. Expert faculty will discuss preventing acute kidney injury in patients at risk of TLS and identifying treatment strategies based on patient risk factors. The practical application of current TLS prevention and management strategies will be discussed through case studies.
Faculty
Jorge E. Cortes, MD
Professor of Medicine and Internist
Deputy Chair, Department of Leukemia
University of Texas MD Anderson Cancer Center
Houston, TX
Credits available: A maximum of 0.5 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
Expires: 9/29/10
This activity has been approved for AMA PRA Category 1 Credit™
Supported by an educational grant from:
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
